Guobang Pharma Ltd (605507) — Cash Flow Reinvestment Rate
Guobang Pharma Ltd (605507) has a Cash Flow Reinvestment Rate of 0.36x as of September 2025, reinvesting CN¥110.58 Million (capex CN¥110.58 Million ) from operating cash flow of CN¥311.27 Million. Check Guobang Pharma Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guobang Pharma Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Guobang Pharma Ltd across 8 annual periods. Explore 605507 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Guobang Pharma Ltd (2017–2025)
Year-by-year capital reinvestment analysis for Guobang Pharma Ltd. For live market cap and broader valuation context, see 605507 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.57x | CN¥875.56 Million | CN¥559.28 Million | CN¥277.71 Million | ▲ +108.0% |
| 2024 | 0.75x | CN¥531.80 Million | CN¥706.41 Million | CN¥419.12 Million | ▼ -64.9% |
| 2023 | 2.15x | CN¥1.11 Billion | CN¥516.76 Million | CN¥748.44 Million | ▲ +79.8% |
| 2022 | 1.19x | CN¥1.21 Billion | CN¥1.02 Billion | CN¥803.12 Million | ▲ +3.6% |
| 2020 | 1.15x | CN¥885.39 Million | CN¥767.70 Million | CN¥520.16 Million | ▼ -44.3% |
| 2019 | 2.07x | CN¥912.52 Million | CN¥440.86 Million | CN¥605.18 Million | ▲ +586.8% |
| 2018 | 0.30x | CN¥163.24 Million | CN¥541.68 Million | CN¥163.24 Million | ▼ -73.7% |
| 2017 | 1.14x | CN¥169.48 Million | CN¥148.03 Million | CN¥169.48 Million | — |